Ingesta de calcio y densidad mineral ósea en adolescentes chilenos con desarrollo puberal completo

Introducción: La cantidad diaria recomendada (RDA) de calcio en adolescentes es de 1.300 mg/día. La última Encuesta Nacional de Consumo Alimentario de Chile, mostró que la mediana de ingesta total de calcio fue menos de la mitad de la RDA. Una ingesta insuficiente de calcio puede impactar negativamente la mineralización ósea. Objetivo: Determinar el efecto de la ingesta de calcio y estado nutricional sobre la densidad mineral ósea (DMO) de adolescentes con desarrollo puberal completo. Métodos: Estudio de corte transversal. Participaron n= 79 adolescentes de ambos sexos de entre 17 y 18 años elegidos al azar, aparentemente sanos, estadio Tanner 5 e IMC-1 DE). Según estado nutricional, no hubo diferencias significativas en la ingesta de nutrientes, pero sí en la DMO. En media, la DMO estandarizada (puntaje Z) fue normal para ambos sexos (>-1 DE); los adolescentes con obesidad presentaron una DMO estandarizada significativamente mayor que los adolescentes de peso normal (1,05±0,85 vs 0.33±0,86; P= 0,04). La ingesta de calcio no se relacionó con la masa ósea total ni con la DMO estandarizada. Conclusión: En adolescentes con desarrollo puberal completo no hubo relación entre la ingesta de calcio y los niveles de mineralización ósea. Sí hubo relación entre mineralización ósea y estado nutricional, siendo mayor la DMO en los individuos con obesidad.

Background: In adolescents, the recommended daily intake (RDI) of calcium is 1,300 mg. In Chile, the latest National Survey of Food Consumption showed that the median total calcium intake was less than half of the RDI. An adequate intake of calcium in adolescence negatively affects BMD. Aim: To determine the association of calcium intake and nutritional status with bone mineral density (BMD) in male and female adolescents with completed pubertal development (Tanner 5). Methods: Cross-sectional study in a random sample of 79 male and female adolescents, ages 17-18. Participants were healthy, Tanner stage 5, and BMI −1 SD. BMD was higher in obese participants compared to normal-weight adolescents (1.05±0.85 vs 0.33±0.86; P= 0.04), although no differences in nutrients and food intake. Calcium intake was unrelated to total bone mass and unstandardized BMD. Conclusions: In our sample of adolescents with complete pubertal development, there was no relationship between calcium intake and bone mineralization levels. There was a significant relationship between bone mineralization and nutritional status, with BMD being higher in adolescents with obesity.

Deficiencias de cobre, hierro y zinc en niños menores de 5 años

Introducción: La determinación de niveles séricos de micronutrientes de los niños menores de 5 años, es un requerimiento básico para establecer la prevalencia de deficiencias nutricionales de la población infantil y es una estrategia útil para incentivar a Salud Pública para que tome medidas en cuanto a aplicación y/o modificación de las Políticas Alimentarias Nacionales. Objetivo: Determinar los niveles séricos de cobre, hierro y zinc en niños paraguayos menores de 5 años. Materiales y Métodos: Estudio observacional, descriptivo y de corte transversal. Se procesaron las muestras de sangre de 1.441 niños menores de 5 años de edad que provenían de los Departamentos de Alto Paraná, Caaguazú, Central y de la capital de Paraguay. Se realizaron hemogramas y se determinaron las concentraciones séricas de albúmina, cobre, ferritina y zinc, de todas las muestras. Resultados: Los niños tuvieron una edad promedio de 3 años y 3 meses, fueron 52,74% de sexo masculino y 47,26% de sexo femenino. La prevalencia de anemia fue de 45,25% y la prevalencia de hipoalbuminemia fue de 20,65%. Se detectaron deficiencias de cobre en 14,03%, de ferritina en 6,98% y de zinc en 43,62%, de los niños. Conclusión: Los resultados de este estudio avalan la necesidad de ampliar la cobertura del Programa Alimentario Nutricional Integral (PANI), de plantearse si se deben ajustar las cantidades de minerales y vitaminas de la fórmula nutricional del Programa y de mejorar el seguimiento de los controles prenatales de las madres.

Introduction: The determination of serum levels of micronutrients in children under 5 years of age is a basic requirement to establish the prevalence of nutritional deficiencies in the child population and is a useful strategy to encourage Public Health agencies to take steps regarding application. and/or modification of National Food Policies. Objective: To determine the serum levels of copper, iron and zinc in Paraguayan children under 5 years of age. Materials and Methods: This was an observational, descriptive and cross-sectional study. Blood samples from 1,441 children under 5 years of age who came from the Departments of Alto Paraná, Caaguazú, Central and the capital of Paraguay were processed. Complete blood counts were performed and the serum concentrations of albumin, copper, ferritin and zinc were determined in all samples. Results: The children in this study had an average age of 3 years and 3 months, they were 52.74% male and 47.26% female. The prevalence of anemia was 45.25% and the prevalence of hypoalbuminemia was 20.65%. Copper deficiencies were detected in 14.03%, ferritin in 6.98% and zinc in 43.62% of the children. Conclusion: The results of this study support the need to expand the coverage of the Comprehensive Nutritional Food Program (PANI program), to consider whether the amounts of minerals and vitamins in the Program's nutritional formula should be adjusted, and to improve prenatal care.

Prevalencia de anemia en niños de 1 a 4 años de edad en Asunción y Central, Paraguay 2017

RESUMEN Introducción: Los niños constituyen el grupo más afectado por la anemia. En Paraguay no existen datos actualizados sobre prevalencia de anemia en menores de 5 años. Objetivos: Determinar la prevalencia de anemia en niños previamente sanos de 1 a 4 años que acuden a consultorios de servicios de salud y guarderías de Asunción y Central de Paraguay, durante el año 2017. Materiales y Métodos: Estudio prospectivo, de corte transverso, observacional, descriptivo. Muestreo aleatorio, estratificado. Nivel de confianza: 95% Error de muestra: 5%. Variables: edad, sexo, hemoglobina, índices hematimétricos, ferritina, Proteína C reactiva (PCR), albúmina, zPeso/Edad, zPeso/Talla, zTalla/Edad, peso al nacer. Fueron analizadas medidas paramétricas y no paramétricas, χ2. La anemia se definió por criterios OMS para el grupo de 1 a 5 años de edad: Hemoglobina Hb<11 g/dL y Volumen Corpuscular Medio VCM< 72 fL Se utilizó el Programa Anthro v 3.2.2 y SPSS 16.0. Aprobado por Comité de Ética del Instituto de Medicina Tropical, se obtuvo consentimiento informado. Nivel de significancia<0,05. Resultados: Fueron reclutados 806 pacientes. Se determinó Hb, VCM y ferritina en 706 pacientes.327 (46,3%) fueron varones. El promedio de Hb fue 11,9±1,03 g/dL. Volumen corpuscular medio promedio 71,2±26 fL. Se encontraron 83/706 pacientes con anemia (11,8%), 44/83 (53%) fueron microcíticas (VMC<72 fL). PCR negativa 640/706 (90,7%) pacientes. El promedio de albuminemia fue 4,5±0,2 g/dL. El promedio de z Peso/Edad fue 0,29±1,33, z Peso/Talla -0,38±1,52 y el z Talla/Edad fue 0,92±1,64. Ferritina < 12µg/L fue del 17,6 %. No se encontró relación entre el peso al nacer y la anemia [p=0,11. RR: 1,45 (0,6- 2,3)]. La prevalencia de anemia en el grupo de 12 a 23 meses fue del 39 % vs el 6,9 % en preescolares (χ2 p<0,05). Conclusiones: La prevalencia de anemia en lactantes de Asunción y Central constituye un problema de salud pública.

ABSTRACT Introduction: Children are the group most affected by anemia. In Paraguay there are no updated data on the prevalence of anemia in children under 5 years of age. Objectives: To determine the prevalence of anemia in previously healthy children aged 1 to 4 years who presented to health services clinics and nurseries in Asunción and the Central Department, Paraguay, during the year 2017. Materials and Methods: This was a prospective, cross-sectional, observational descriptive study. We used random, stratified sampling. Confidence level: 95% Sample error: 5%. Variables: age, sex, hemoglobin, hematometric indices, ferritin, C-reactive protein (CRP), albumin, z Weight / Age, z Weight / Height, z Height / Age, birth weight. Parametric and non-parametric measures, χ2, were analyzed. Anemia was defined by WHO criteria for the 1 to 5 year-old group: Hemoglobin Hb <11 g / dL and Mean Corpuscular Volume MCV <72 fL The Anthro Program v 3.2.2 and SPSS 16.0 were used. The study was approved by the Ethics Committee of the Institute of Tropical Medicine, and informed consent was obtained. Significance level <0.05. Results: 806 patients were recruited. Hgb, MCV and ferritin were determined in 706 patients. 327 (46.3%) were male. The mean Hgb was 11.9 ± 1.03 g / dL. Mean corpuscular volume 71.2 ± 26 fL. 83/706 patients with anemia (11.8%) were found, 44/83 (53%) were microcytic (MCV <72 fL). Negative CRP 640/706 (90.7%) patients. Average albuminemia was 4.5 ± 0.2 g / dL. The mean of z Weight / Age was 0.29 ± 1.33, z Weight / Height -0.38 ± 1.52 and the z Height / Age was 0.92 ± 1.64. Ferritin <12µg / L was 17.6%. No relationship was found between birth weight and anemia [p = 0.11. RR: 1.45 (0.6-2.3)]. The prevalence of anemia in the 12 to 23 month group was 39% vs 6.9% in preschool children (χ2 p <0.05). Conclusions: The prevalence of anemia in infants from Asunción and the Central Department constitutes a public health problem.

Exploratory Study: Excessive Iron Supplementation Reduces Zinc Content in Pork without Affecting Iron and Copper.

The aim of this work was to determine in an exploratory manner the effect of excessive iron supplementation on iron, zinc, and copper contents in pork and pork offal. Pigs averaging 50 days in age and 15 ± 1.3 kg body weight were allocated to a control group (500 ppm dietary Fe) and a supplemental group (3000 ppm dietary Fe). After an iron supplementation period of 60 days, blood samples were analyzed to determine iron biomarkers, serum copper, and zinc contents. Animals were slaughtered to assess total iron, non-heme iron, heme iron, zinc, and copper contents in samples of nine meat cuts and some offal. Iron supplementation improved the iron status in pigs with increased hemoglobin and hematocrit, but did not affect serum levels of iron, zinc, and copper. Iron supplementation did not affect the heme and non-heme iron contents of the different meat cuts. Zinc contents decreased by 32-55% in meat cuts, where iron content increased in the liver, spleen, kidneys, and pancreas. No differences of zinc and copper were observed in offal samples. High concentrations of iron supplementation reduce zinc content in pork.

Zinc absorption and zinc status are reduced after either sleeve gastrectomy or Roux-en-Y gastric bypass in premenopausal women with severe obesity studied prospectively over 24 postoperative months.

BACKGROUND: Roux-en-Y gastric bypass (RYGBP) is known to reduce zinc absorption; the effects of vertical sleeve gastrectomy (SG) and its long-term implications on zinc absorption have not yet been studied. OBJECTIVE: The aim was to evaluate the effects of SG and RYGBP on zinc absorption and zinc status in premenopausal women with severe obesity up to 24 mo after surgery. METHODS: Twenty-six premenopausal women undergoing SG [BMI (in kg/m2): 37.3 ± 3.2] and 32 undergoing RYGBP (BMI: 42.0 ± 4.2) were studied. A series of anthropometric, dietary, and zinc status parameters (plasma and hair zinc), and the size of the exchangeable zinc pool (EZP), as well as percentage zinc absorption from a standardized dose using a stable isotope methodology were evaluated in the patients before the surgical procedure and at 12 and 24 mo after SG or RYGBP. SG patients received 15 mg and RYGBP received 25 mg of supplemental Zn/d. RESULTS: In premenopausal women, zinc absorption was decreased by 71.9% and 52.0% in SG and RYGBP, respectively, 24 mo postsurgery, compared with initial values. According to 2-factor repeated-measures ANOVA, time effect was significant (P = <0.0001), but not time × group interaction (P = 0.470). Plasma zinc below the cutoff point of 70 µg/dL increased from 0 to 15.4% and 38.1% in SG and RYGBP, respectively. Mean EZP was significantly reduced 24 mo after surgery, although no time × group interactions were observed. Hair zinc did not change across time or between groups. CONCLUSIONS: Both SG and RYGBP have profound effects on zinc absorption capacity, which are not compensated for after 24 mo. Although zinc absorption reduction was similar in both types of surgeries, plasma zinc was more affected in RYGBP than SG, despite greater zinc supplementation in RYGBP.This trial was registered at http://www.isrctn.com as ISRCTN31937503.

Efecto de la suplementación con vitamina D en dosis única sobre el estado nutricional de vitamina D / Effect of vitamin D supplementation as a single dose on the nutritional status of vitamin D

INTRODUCCIÓN: El primer año de vida es un periodo de riesgo de deficiencia de vitamina D (VD). La administración de 400 UI diarias de VD no tiene una adherencia del 100%, en cambio dosis únicas de 100.000 UI de VD oral son seguras en recién nacidos. OBJETIVO: Comparar el efecto de la suplementación oral de VD en dosis única de 100.000 UI al mes de edad vs dosis diarias de 400 UI sobre las concentraciones séricas de VD, a los 6 meses de vida. SUJETOS Y MÉTODOS: Ensayo clínico aleatorizado, sin enmascaramiento. Se incluyeron 84 lactantes sanos de 1 mes de vida, asignados al azar al grupo de estudio (GE) que recibió una dosis única de VD de 100.000 UI oral o al grupo control (GC), que recibió dosis diarias de VD de 400 UI oral del 1er al 6to mes de vida. A los 6 meses de edad se determinó la concentración sérica de VD. RESULTADOS: 65 lactantes terminaron el estudio, 36 en GE y 29 en GC. No se encontró deficiencia de VD. La insuficiencia de VD fue de 5,5% y 6,8% en el GE y GC, respectivamente. La concentración sérica de VD a los 6 meses de vida, fue de 38,8 ± 5,2 ng/ml y 39,7 ± 6,3 ng/ml para GE y GC, respectivamente (NS). CONCLUSIONES: La suplementación con 100.000 UI de VD única al mes de edad logra concentraciones séricas de VD a los 6 meses de vida, similares a dosis diarias de 400 UI de VD, del 1er al 6to mes.

INTRODUCTION: Infants are a group at risk of vitamin D (VD) deficiency. The administration of 400 IU of VD per day during the first year of life does not achieve 100% adherence. A single dose of 100,000 IU of oral VD is safe in newborns. OBJECTIVE: To compare the effect of oral administration of VD between a single dose of 100,000 IU at one month of age vs daily doses of 400 IU on serum concentrations of VD, at 6 months of age. SUBJECTS AND METHOD: Randomized clinical trial, without masking. 84 healthy infants were included at 1 month of age, randomized to the study group (SG) receiving a single oral dose of 100,000 IU or to the control group (CG), who received daily oral doses of VD of 400 IU from the 1st to the 6th month of life. At 6 months of life, the serum concentration of VD was determined. RESULTS: 65 infants completed the study, 36 in SG and 29 in CG. No VD deficiency was found. VD insufficient was 5.5% and 6.8% in the SG and CG, respectively. The serum concentration of VD at six months of age was 38.8 ± 5.2 ng/ml and 39.7 ± 6.3 ng/ml for the SG and CG, respectively (NS). CONCLUSIONS: Supplementation of 100,000 IU of VD at one month age achieves serum concentrations of VD at 6 months of life similar to the administration of daily doses of 400 IU of VD from the 1st to the 6th month.

Effect of vitamin D supplementation as a single dose on the nutritional status of vitamin D. / Efecto de la suplementación con vitamina D en dosis única sobre el estado nutricional de vitamina D.

INTRODUCTION: Infants are a group at risk of vitamin D (VD) deficiency. The administration of 400 IU of VD per day during the first year of life does not achieve 100% adherence. A single dose of 100,000 IU of oral VD is safe in newborns. OBJECTIVE: To compare the effect of oral administration of VD between a single dose of 100,000 IU at one month of age vs daily doses of 400 IU on serum concentrations of VD, at 6 months of age. SUBJECTS AND METHOD: Randomized clinical trial, without masking. 84 healthy infants were included at 1 month of age, randomized to the study group (SG) receiving a single oral dose of 100,000 IU or to the control group (CG), who received daily oral doses of VD of 400 IU from the 1st to the 6th month of life. At 6 months of life, the serum concentration of VD was determined. RESULTS: 65 infants completed the study, 36 in SG and 29 in CG. No VD deficiency was found. VD insufficient was 5.5% and 6.8% in the SG and CG, respectively. The serum concentration of VD at six months of age was 38.8 ± 5.2 ng/ml and 39.7 ± 6.3 ng/ml for the SG and CG, respectively (NS). CONCLUSIONS: Supplementation of 100,000 IU of VD at one month age achieves serum concentrations of VD at 6 months of life similar to the administration of daily doses of 400 IU of VD from the 1st to the 6th month.

Clinical parameters, LysoGb3, podocyturia, and kidney biopsy in children with Fabry disease: is a correlation possible?

BACKGROUND: Fabry disease is an X-linked lysosomal storage disorder caused by α-galactosidase enzyme deficiency. We present clinical, biochemical, and histologic findings in children with classical phenotypic presentation of Fabry disease. METHODS: A retrospective analysis was performed using charts from 14 children with confirmed diagnosis. Clinical parameters were evaluated. Globotriaosylsphingosine -lysoGb3- detection in plasma, podocyturia, and kidney biopsy were carried out in all cases. RESULTS: All patients except one demonstrated at least one symptom of Fabry disease. LysoGb3 levels were above the normal range in all patients. Podocyturia was documented in all patients. Kidney biopsy revealed glomerular, interstitial, vascular, and tubular changes on light microscopy in nearly all patients. Electron microscopy showed podocyte inclusions in all patients. CONCLUSIONS: No difference in symptomatology was discernible between boys and girls. Podocyturia was detectable in children serving as a possible early marker of kidney injury. LysoGb3 was elevated in all cases, emphasizing the importance for diagnosis especially in female patients with normal αGal A activity. A possible association between lysoGb3 and symptom severity and histological involvement in kidney biopsy should be assessed in prospective studies with enough statistical power to determine if lysoGb3 can be used to predict nephropathy in children with Fabry disease.

Effect of various calcium salts on non-heme iron bioavailability in fasted women of childbearing age.

INTRODUCTION: Micronutrient deficiencies are one of the most important public health issues worldwide and iron (Fe) deficiency anemia is the most prevalent micronutrient deficiency. Iron deficiency often coexists with calcium deficiency and iron and calcium supplementation often overlap. This has led to investigations into the interaction between these two minerals, and whether calcium may inhibit iron absorption in the gut. OBJECTIVE: To determine the effect of various calcium salts on non-heme iron bioavailability in fasted women of childbearing age. METHODS: A randomized and single blinded trial was conducted on 27 women of childbearing age (35-45 years old) divided into 2 groups (n1 = 13 and n2 = 14, respectively). On four different days, after an overnight fast, they received 5 mg of Fe as FeSO4 (labeled with 55Fe or 59Fe) with 800 mg of elemental calcium in the form of either calcium chloride, calcium gluconate, calcium citrate, calcium carbonate, calcium lactate, calcium sulfate or calcium phosphate. Calcium chloride was used as the control salt in both groups. Iron was labeled with the radioisotopes 59Fe or 55Fe, and the absorption of iron was measured by erythrocyte incorporation of radioactive Fe RESULTS: 800 mg of elemental calcium as calcium citrate produced a significant decrease in non-heme iron bioavailability (repeated measures ANOVA, F = 3.79, p = 0.018). CONCLUSION: Of the various calcium salts tested, calcium citrate was the only salt that decreased non-heme iron bioavailability relative to the calcium chloride control when taken on an empty stomach. These results suggest that inhibition of non-heme iron absorption in fasted individuals is dependent upon the calcium salt in question and not solely dependent on the presence of calcium.

Pectin Esterification Degree in the Bioavailability of Non-heme Iron in Women.

Pectins are a type of soluble fiber present in natural and processed foods. Evidence regarding the effect of esterification degree of pectins on iron absorption in humans is scarce. In the present study, the effect of pectins with different degrees of esterification on non-heme iron absorption in women was evaluated. A controlled experimental study was conducted with block design, involving 13 apparently healthy, adult women. Each subject received 5 mg Fe (FeSO4) without pectin (control) or accompanied by 5 g citrus pectin, two with a low degree of esterification (27 and 36%), and one with a high degree of esterification (67 to 73%), each on different days. Each day, the 5 mg Fe doses were marked with radioactive 59Fe or 55Fe. Radioactivity incorporated into erythrocytes was determined in blood samples 14 days after the marked Fe doses were consumed. On days 18 and 36 of study, 30 and 20 mL blood samples were obtained, respectively, and blood sample radioactivity incorporated into erythrocytes was determined. Body iron status was determined from blood taken on day 18. Whole body blood volume was estimated for calculate iron bioavailability; it was assumed that 80% of absorbed radioactivity was incorporated into the Hb. All women participants signed an informed consent of participation at baseline. Iron bioavailability (mean geometric ±1 SD) alone (control) was 18.2% (12.3-27.1%), iron + pectin27 was 17.2% (10.2-29.2%), iron + pectin36 was 15.3% (9.5-24.6%), and iron + pectin67 was 19.5% (10.0-38.0%). No statistically significant differences between iron bioavailability (repeated measures ANOVA, p = 0.22) were observed. Pectin esterification degree does not influence the bioavailability of non-heme iron in women.

Optimization of radiotherapy fractionation schedules based on radiobiological functions.

OBJECTIVE: To present a method for optimizing radiotherapy fractionation schedules using radiobiological tools and taking into account the patient´s dose-volume histograms (DVH). METHODS: This method uses a figure of merit based on the uncomplicated tumour control probability (P+) and the generalized equivalent uniform dose (gEUD). A set of doses per fraction is selected in order to find the dose per fraction and the total dose, thus maximizing the figure of merit and leading to a biologically effective dose that is similar to the prescribed schedule. RESULTS: As a clinical example, a fractionation schedule for a prostate treatment plan is optimized and presented herein. From a prescription schedule of 70 Gy/35 × 2 Gy, the resulting optimal schema, using a figure of merit which only takes into account P+, is 54.4 Gy/16 × 3.4 Gy. If the gEUD is included in that figure of merit, the result is 65 Gy/26 × 2.5 Gy. Alternative schedules, which include tumour control probability (TCP) and the normal tissue complication probability (NTCP) values are likewise shown. This allows us to compare different schedules instead of solely finding the optimal value, as other possible clinical factors must be taken into account to make the best decision for treatment. CONCLUSION: The treatment schedule can be optimized for each patient through radiobiological analysis. The optimization process shown below offers physicians alternative schedules that meet the objectives of the prescribed radiotherapy. Advances in knowledge: This article provides a simple, radiobiological-function-based method to take advantage of a patient's dose-volume histograms in order to better select the most suitable treatment schedule.

Prebiotics increase heme iron bioavailability and do not affect non-heme iron bioavailability in humans.

The aim of this study was to establish the effect of a prebiotic mix on heme and non-heme iron (Fe) bioavailability in humans. To this purpose, twenty-four healthy women were randomized into one of two study groups. One group ate one yogurt per day for 12 days with a prebiotic mix (prebiotic group) and the other group received the same yogurt but without the prebiotic mix (control group). Before and after the intake period, the subjects participated in Fe absorption studies. These studies used 55Fe and 59Fe radioactive isotopes as markers of heme Fe and non-heme Fe, respectively, and Fe absorption was measured by the incorporation of radioactive Fe into erythrocytes. The results showed that there were no significant differences in heme and non-heme Fe bioavailability in the control group. Heme Fe bioavailability of the prebiotic group increased significantly by 56% post-prebiotic intake. There were no significant differences in non-heme Fe bioavailability in this group. We concluded that daily consumption of a prebiotic mix increases heme Fe bioavailability and does not affect non-heme iron bioavailability.

Aceptabilidad, consumo y tolerancia del complemento alimentario "leche enriquecida" en niños beneficiarios del Programa Alimentario Nutricional Integral

Introducción: Una de las mayores dificultades de los programas de alimentación complementaria es determinar cuál es el alimento más adecuado para mejorar el aporte nutricional, que presente una buena tolerancia y bajo nivel de rechazo. En Paraguay, el Instituto Nacional de Alimentación y Nutrición dependiente del Ministerio de Salud Pública y Bienestar Social cuenta con un programa alimentario nutricional integral, que no disponía de ninguna evaluación previa de la aceptación de su producto alimentario. Objetivo: Describir la aceptabilidad, consumo y tolerancia del complemento alimentario "Leche Enriquecida" en niños beneficiarios del Programa Alimentario Nutricional Integral. Método: Estudio descriptivo, retrospectivo. Muestreo no probabilístico, por casos consecutivos. Incluyó a los padres y/o cuidadores de niños beneficiarios del Programa Alimentario Nutricional Integral (PANI) que acudieron a los servicios de salud de Concepción, Guaira y Caaguazú durante los años 2010 y 2011. La aceptabilidad del complemento alimentario se midió mediante una encuesta realizada a los padres y/o cuidadores de los niños participantes del estudio. Resultados: En el estudio participaron 86 padres y cuidadores de niños menores de cinco años de edad. 44/86 de las madres consideraron que al niño le gusta mucho el complemento alimentario, la mayor parte de los beneficiarios consumieron el complemento todos los días (n=75). 85/86 de la población estudiada no presentó intolerancia a la leche enriquecida. Conclusión: El complemento nutricional presenta una excelente aceptabilidad, consumo y tolerancia por parte de los beneficiarios.

Introduction: One of the major difficulties of complementary feeding programs is to determine which food is the most adequate to improve nutritional intake, which has a good tolerance and a low level of rejection. In Paraguay, the National Institute of Food and Nutrition under the Ministry of Public Health and Social Welfare has a comprehensive nutritional food program, this program has no evaluation of the acceptance of its food product. Objective: Describe the acceptability, consumption and tolerance of the enriched milk supplement in children beneficiaries of the Integral Nutritional Feeding Program. Method: A retrospective descriptive study that included parents and / or caregivers of children from the Integral Nutritional Food Program (PANI) who attended the health services of Concepción, Guaira and Caaguazú during the years 2010 and 2011. Not probabilistic consecutive sampling cases. The acceptability of the food supplement was measured by a survey of the parents and/or caregivers of the children participating in the study. Results: The study involved 86 children under five years of age. 44/86 of the mothers consider that the child is very fond of the food supplement, most of the recipients consumed the supplement every day (n=75). 85/86 of the population studied did not have complement intolerance. Conclusion: The nutritional supplement presents excellent acceptability, consumption and tolerance on the part of the beneficiaries.

Encapsulación de hierro: Otra estrategia para la prevención o tratamiento de la anemia por deficiencia de hierro / Iron encapsulation: Another strategy for the prevention or treatment of iron deficiency anemia

RESUMEN La anemia por deficiencia de hierro afecta a un tercio de la población mundial, causando severos problemas de salud. Las estrategias de prevención y tratamiento se basan en la suplementación oral y fortificación de alimentos, pero su eficacia no ha sido la esperada. Una de las causas se debe a que los compuestos de hierro utilizados tienen baja biodisponibilidad y producen efectos indeseados. Por esto, se han buscado nuevas tecnologías que pudiesen evitar estos problemas, como la encapsulación. Esta tecnología mejora la biodisponibilidad del hierro, reduce alteraciones organolépticas de los productos fortificados, y disminuye los trastornos gastrointestinales del uso de suplementos, entre las principales ventajas. Estos productos de hierro encapsulados han sido estudiados in vitro, y también aplicados en estudios in vivo para determinar su eficacia contra la anemia por deficiencia de hierro, con promisorios resultados. Por tanto, el objetivo de esta revisión fue recopilar información acerca de las tendencias actuales de encapsulación de hierro como una herramienta para prevenir o tratar la anemia por deficiencia de hierro.

ABSTRACT Iron deficiency anemia affects one third of the world population, causing severe health problems. Prevention and treatment strategies are based on oral supplementation and fortification of foods, but the effectiveness of these strategies has not been as expected. One explanation is that the iron compounds used have low bioavailability and produce undesired effects. Therefore, new technologies that could avoid these problems, like the encapsulation, have been explored. This technology improves the bioavailability of iron, reduces organoleptic alterations of fortified products, and decreases gastrointestinal disorders related to supplement use. These encapsulated iron products have been studied in vitro and also applied in in vivo studies to determine their efficacy against iron deficiency anemia, with promising results. Therefore, the objective of this review was to gather information about current trends in iron encapsulation as a tool to prevent or treat iron deficiency anemia.

Heme Iron Release from Alginate Beads at In Vitro Simulated Gastrointestinal Conditions.

Heme iron (Fe) release from alginate beads at in vitro simulated gastrointestinal conditions for potential use as oral heme Fe supplement was studied. Five beads at different ratios of sodium alginate (SA)-to-spray-dried bovine blood cells (SDBC) with weight ratios of 1:1.25, 1:2.5, 1:5, 1:10, and 1:15 (w/w) were prepared. Release characteristics of these beads were investigated at in vitro simulated gastrointestinal conditions. Release media pH strongly influenced the controlled Fe release from the beads. The heme Fe-beads in simulated gastric fluid (pH 2) remained in a shrinkage state and Fe release was low: 25.8, 21.1, 11.6, 12.1, and 12.0 % for 1:1.25, 1:2.5, 1:5, 1:10, and 1:15 ratios, respectively. Proportion and amount of Fe released by 1:1.25 and 1:2.5 ratios was higher than the other ratios. The heme Fe-beads swelled and dissociated in simulated intestinal fluid (pH 6), releasing three-fourths of the Fe in 200 min. The morphology studies showed that Fe release followed formation of pores in the alginate matrix, generating erosion of the beads and complete disintegration after 75 and 200 min of gastric and intestinal incubation, respectively. These results indicate that heme Fe-beads may be useful for oral delivery of heme Fe supplement.

The effect of proteins from animal source foods on heme iron bioavailability in humans.

Forty-five women (35-45 year) were randomly assigned to three iron (Fe) absorption sub-studies, which measured the effects of dietary animal proteins on the absorption of heme Fe. Study 1 was focused on heme, red blood cell concentrate (RBCC), hemoglobin (Hb), RBCC+beef meat; study 2 on heme, heme+fish, chicken, and beef; and study 3 on heme and heme+purified animal protein (casein, collagen, albumin). Study 1: the bioavailability of heme Fe from Hb was similar to heme only (∼13.0%). RBCC (25.0%) and RBCC+beef (21.3%) were found to be increased 2- and 1.6-fold, respectively, when compared with heme alone (p<0.05). Study 2: the bioavailability from heme alone (10.3%) was reduced (p<0.05) when it was blended with fish (7.1%) and chicken (4.9%), however it was unaffected by beef. Study 3: casein, collagen, and albumin did not affect the bioavailability of Fe. Proteins from animal source foods and their digestion products did not enhance heme Fe absorption.

Acute Copper and Ascorbic Acid Supplementation Inhibits Non-heme Iron Absorption in Humans.

The objective of the study is to determine the effect of copper (Cu) plus the reducing agent ascorbic acid (AA) on the absorption of non-heme iron (Fe). Experimental study with block design in which each subject was his own control. After signing an informed consent, 14 adult women using an effective method of contraception and negative pregnancy test received 0.5 mg Fe, as ferrous sulfate, alone or with Cu, as copper sulfate, plus ascorbic acid (AA/Cu 2/1 molar ratio) at 4/1; 6/1 and 8/1 Cu/Fe molar ratios as an aqueous solution on days 1, 2, 14, and 15 of the study. Fe absorption was assessed by erythrocyte incorporation of iron radioisotopes (55)Fe and (59)Fe. Geometric mean (range ± SD) absorption of Fe at 4/1 and 6/1 Cu/Fe molar ratios (and AA/Cu 2/1 molar ratio) and Fe alone was 57.4 % (35.7-92.1 %), 64.2 % (45.8-89.9 %), and 38.8 % (20.4-73.8 %), respectively (ANOVA for repeated measures p < 0.001; post hoc test Scheffé, p < 0.05). This is attributable to the enhancing effect of AA on non-heme Fe absorption; however, Fe absorption at Cu/Fe 8/1 molar ratio was 47.3 % (27.7-80.8) (p = NS compared with Fe alone). It was expected that Fe absorption would have been equal or greater than at 4/1 and 6/1 molar ratios. Copper in the presence of ascorbic acid inhibits non-heme Fe absorption at Cu/Fe 8/1 molar ratio.

Iron Absorption from Two Milk Formulas Fortified with Iron Sulfate Stabilized with Maltodextrin and Citric Acid.

BACKGROUND: Fortification of milk formulas with iron is a strategy widely used, but the absorption of non-heme iron is low. The purpose of this study was to measure the bioavailability of two iron fortified milk formulas designed to cover toddlers´ nutritional needs. These milks were fortified with iron sulfate stabilized with maltodextrin and citric acid. METHODS: 15 women (33-47 years old) participated in study. They received on different days, after an overnight fast, 200 mL of Formula A; 200 mL of Formula B; 30 mL of a solution of iron and ascorbic acid as reference dose and 200 mL of full fat cow's milk fortified with iron as ferrous sulfate. Milk formulas and reference dose were labeled with radioisotopes (59)Fe or (55)Fe, and the absorption of iron measured by erythrocyte incorporation of radioactive Fe. RESULTS: The geometric mean iron absorption corrected to 40% of the reference dose was 20.6% for Formula A and 20.7% for Formula B, versus 7.5% of iron fortified cow's milk (p < 0.001). The post hoc Sheffé indeed differences between the milk formulas and the cow's milk (p < 0.001). CONCLUSION: Formulas A and B contain highly bioavailable iron, which contributes to covering toddlers´ requirements of this micronutrient.

The Effect of Plant Proteins Derived from Cereals and Legumes on Heme Iron Absorption.

The aim of this study is to determine the effect of proteins from cereals and legumes on heme iron (Fe) absorption. The absorption of heme Fe without its native globin was measured. Thirty adult females participated in two experimental studies (15 per study). Study I focused on the effects of cereal proteins (zein, gliadin and glutelin) and study II on the effects of legume proteins (soy, pea and lentil) on heme Fe absorption. When heme was given alone (as a control), study I and II yielded 6.2% and 11.0% heme absorption (p > 0.05). In study I, heme Fe absorption was 7.2%, 7.5% and 5.9% when zein, gliadin and glutelin were added, respectively. From this, it was concluded that cereal proteins did not affect heme Fe absorption. In study II, heme Fe absorption was 7.3%, 8.1% and 9.1% with the addition of soy, pea and lentil proteins, respectively. Only soy proteins decreased heme Fe absorption (p < 0.05). These results suggest that with the exception of soy proteins, which decreased absorption, proteins derived from cereals and legumes do not affect heme Fe absorption.

Effect of daily supplementation with iron and zinc on iron status of childbearing age women.

The objective was to determine the effect of daily supplementation with 30 mg of iron (Fe) plus 30 mg of zinc (Zn) for 3 months on Fe status of women of childbearing age. This was a randomized double-blind, placebo-controlled trial. Eighty-one women (18-45 years) were randomly assigned to receive either a daily single dose of 30 mg of Fe (group 1; n = 28) and 30 mg of Fe plus 30 mg of Zn (group 2; n = 26) or placebo (n = 27) for 3 months. Hemoglobin (Hb), mean corpuscular volume, serum Fe, total iron-binding capacity, transferrin saturation, erythrocyte Zn protoporphyrin, serum ferritin (SF), serum transferrin receptor (TfR), total body Fe, serum Zn, and high-sensitivity C-reactive protein were measured at baseline and at the end of the study. At baseline, 3.7, 28.4, and 3.7 % of women had iron-deficiency anemia (IDA), Fe deficiency without anemia, and depleted Fe stores, respectively. No significant differences on Fe status were found between groups before supplementation. After supplementation, group 2 showed a significant increase of Hb and total body Fe and a significant decrease of TfR compared with placebo (p < 0.05). Moreover, serum Zn increased significantly in group 2 compared with group 1 (p < 0.01) and placebo (p < 0.01). In conclusion, daily supplementation with 30 mg of Fe plus 30 mg of Zn for 3 months improved significantly the Fe and Zn status of women, compared with those who received placebo. The positive effect of Fe supplementation on Fe status is enhanced by combined Zn supplementation.